Rajasthan: Scope of Mukhya Mantri Free Medicine Scheme to be increased

28 Nov, 2024 9:09 PM
Rajasthan: Scope of Mukhya Mantri Free Medicine Scheme to be increased
Jaipur, Nov 28 (IANS) The Rajasthan government is set to expand the scope of the Mukhya Mantri Free Medicine Scheme, as announced during a meeting of the Technical Advisory Committee on Thursday.

The meeting, chaired by Rajasthan Medical Services Corporation Limited Managing Director Neha Giri, focused on enhancing the scheme's offerings.

Several key decisions were made to update the essential medicine list by including new drugs and re-categorising existing ones. The discussion emphasised incorporating medicines vital for treating various diseases. Medical and pharmaceutical experts provided valuable insights on the availability, requirements, and supply chain of medicines.

Giri highlighted that 390 medicines were evaluated during the meeting. Based on the decisions, new medicines will soon be added to the essential medicine list, ensuring better access for patients at nearby medical institutions.

Currently, approximately 4.5 lakh patients benefit daily from the Mukhya Mantri Free Nirogi Dawa Scheme. The initiative operates efficiently through e-medicine software, ensuring seamless supply, distribution, and maintenance of medicines. Presently, 1,240 medicines, 428 surgical items, and 156 sutures are available under the scheme.

For the financial year 2024-25, a budget allocation of ₹2,122 crore has been earmarked to support and enhance the scheme's implementation, officials stated.



Disclaimer   The information contained in this website is for general information purposes only. The information is provided by geo24news.com and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.

We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.

If you are not willing to accept this disclaimer then we recommend reading news post in its original language.





 

 

Scroll to Top